These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7356895)

  • 1. Quantitative analysis of the disopyramide concentration-effect relationship.
    Whiting B; Holford NH; Sheiner LB
    Br J Clin Pharmacol; 1980 Jan; 9(1):67-75. PubMed ID: 7356895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disopyramide serum and pharmacologic effect kinetics applied to the assessment of bioavailability.
    Bryson SM; Whiting B; Lawrence JR
    Br J Clin Pharmacol; 1978 Nov; 6(5):409-19. PubMed ID: 728284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-arrhythmic and haemodynamic effects of intravenous and oral disopyramide in patients with ventricular arrhythmia.
    Hulting J; Rosenhamer G
    J Int Med Res; 1976; 4(1 Suppl):90-5. PubMed ID: 1026537
    [No Abstract]   [Full Text] [Related]  

  • 4. Bioavailability assessment of disopyramide using pharmacokinetic-pharmacodynamic (PK-PD) modeling in the rat.
    Miyazaki M; Maekawa C; Iwanaga K; Morimoto K; Kakemi M
    Biol Pharm Bull; 2000 Nov; 23(11):1363-9. PubMed ID: 11085367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic-pharmacodynamic analysis of unbound disopyramide directly measured in serial plasma samples in man.
    Thibonnier M; Holford NH; Upton RA; Blume CD; Williams RL
    J Pharmacokinet Biopharm; 1984 Dec; 12(6):559-73. PubMed ID: 6398364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Normal" response of the QT interval and QT dispersion following intravenous injection of the sodium channel blocker disopyramide: methodological aspects.
    Nowinski K; Bergfeldt L
    Cardiovasc Drugs Ther; 1995 Aug; 9(4):573-80. PubMed ID: 8547207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some aspects of the clinical pharmacology of intravenous disopyramide after myocardial infarction.
    Hillis WS; Tweddel A; Lorimer AR; Lawrie TD
    J Int Med Res; 1976; 4(1 Suppl):74-7. PubMed ID: 1026533
    [No Abstract]   [Full Text] [Related]  

  • 8. Concurrent use of quinidine and disopyramide: evaluation of serum concentrations and electrocardiographic effects.
    Baker BJ; Gammill J; Massengill J; Schubert E; Karin A; Doherty JE
    Am Heart J; 1983 Jan; 105(1):12-5. PubMed ID: 6849225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulatory effects of intravenous disopyramide in heart failure.
    Jensen G; Uhrenholt A
    J Int Med Res; 1976; 4(1 Suppl):42-5. PubMed ID: 1026527
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of intravenous disopyramide on the hemodynamics of patients hospitalized in intensive care units].
    Boland J; Lisin N; Marcelle R; Carlier J
    Arch Int Pharmacodyn Ther; 1976 Nov; 224(1):145-51. PubMed ID: 1015909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the anticholinergic effects of two formulations of disopyramide in healthy volunteers.
    Longmore J; Berry JL; Szabadi E; Bradshaw CM
    Eur J Clin Pharmacol; 1990; 39(3):305-9. PubMed ID: 2257872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamics of intravenous disopyramide.
    Sutton R
    J Int Med Res; 1976; 4(1 Suppl):46-8. PubMed ID: 1026528
    [No Abstract]   [Full Text] [Related]  

  • 13. In silico assessment of the effects of quinidine, disopyramide and E-4031 on short QT syndrome variant 1 in the human ventricles.
    Luo C; Wang K; Zhang H
    PLoS One; 2017; 12(6):e0179515. PubMed ID: 28632743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemodynamic effects of disopyramide and procainamide in open-chest animals].
    Binetti G; Branzi A; Malini PL; Specchia S; Magelli C; Zannoli R; Magnani B
    G Ital Cardiol; 1978; 8(12):1314-9. PubMed ID: 738572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereoselectivity in the metabolism of disopyramide enantiomers in rat and dog.
    Cook CS; Karim A; Sollman P
    Drug Metab Dispos; 1982; 10(2):116-21. PubMed ID: 6124395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereoselective effects of disopyramide enantiomers in humans.
    Lima JJ; Boudoulas H
    J Cardiovasc Pharmacol; 1987 May; 9(5):594-600. PubMed ID: 2439842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic analysis of the electrocardiographic interaction between disopyramide and erythromycin in rats.
    Hanada E; Ohtani H; Kotaki H; Sawada Y; Sato H; Iga T
    J Pharm Sci; 1999 Feb; 88(2):234-40. PubMed ID: 9950644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of disopyramide on left ventricular performance: the relationship of free and total concentrations of the drug and of its mono-N-dealkylated metabolite to noninvasive indices of function.
    Holt GW; Norris RL; Ravenscroft PJ; Bett JH; Dryburgh LG; Boyle CM
    J Cardiovasc Pharmacol; 1983; 5(1):51-4. PubMed ID: 6186859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and hemodynamic effects of disopyramide phosphate administered i.v. in cardiopathic subjects (author's transl)].
    Chiariello M; Santinelli V; Ferro G; Tari MG; Stanislao M; Condorelli M
    G Ital Cardiol; 1979; 9(9):975-83. PubMed ID: 520746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of disopyramide of left ventricular function: an echocardiographic study of the extent and time course (author's transl)].
    Angermann C; Autenrieth G
    Klin Wochenschr; 1981 Jul; 59(14):803-11. PubMed ID: 7265814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.